{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:46:26Z","timestamp":1759333586679,"version":"3.40.5"},"reference-count":24,"publisher":"Sociedade Brasileira de Cardiologia","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,12]]},"DOI":"10.36660\/abc.20190176","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T19:44:26Z","timestamp":1591127066000},"page":"692-698","source":"Crossref","is-referenced-by-count":8,"title":["Papel da Interleucina 18 e da Prote\u00edna Precursora do Trombo na Doen\u00e7a Arterial Coronariana"],"prefix":"10.36660","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8589-3826","authenticated-orcid":false,"given":"Carlos","family":"Scherr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-6546","authenticated-orcid":false,"given":"Denilson Campos de","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Pozzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kezia","family":"Ataide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talita","family":"Ludmila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio Martins","family":"Mangia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"22636","reference":[{"issue":"1","key":"key20200602154424_B1","first-page":"e6","article-title":"Heart disease and stroke statistics \u2013 2013 update: a report from the American Heart Association","volume":"127","author":"Go","year":"2013","unstructured":"1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics \u2013 2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6-245.","journal-title":"Circulation"},{"issue":"2","key":"key20200602154424_B2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2174\/1568026611313020001","article-title":"Editorial (hot topic: cardiovascular disease biomarkers: from tradition to modernity)","volume":"13","author":"Bouras","year":"2013","unstructured":"2. Bouras G, Deftereos S. Editorial (hot topic: cardiovascular disease biomarkers: from tradition to modernity). Curr Top Med Chem. 2013;13(2):79-81.","journal-title":"Curr Top Med Chem"},{"issue":"19","key":"key20200602154424_B3","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease: molecular basis and practical considerations","volume":"113","author":"Vasan","year":"2006","unstructured":"3. Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation. 2006;113(19):2335-62.","journal-title":"Circulation"},{"issue":"7","key":"key20200602154424_B4","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/jama.290.7.932","article-title":"Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence","volume":"290","author":"Hackam","year":"2003","unstructured":"4. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence. JAMA. 2003;290(7):932-40.","journal-title":"JAMA"},{"issue":"12","key":"key20200602154424_B5","doi-asserted-by":"crossref","DOI":"10.1007\/s11886-014-0547-7","article-title":"Biomarkers of plaque instability","volume":"16","author":"Shah","year":"2014","unstructured":"5. Shah PK. Biomarkers of plaque instability. Curr Cardiol Rep. 2014;16(12):547.","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"key20200602154424_B6","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2796.2000.00660.x","article-title":"Immunomodulation of atherosclerosis: myth and reality","volume":"247","author":"Nicolletti","year":"2000","unstructured":"6. Nicolletti A, Caligiuri G, Hansson GK. Immunomodulation of atherosclerosis: myth and reality. J Intern Med. 2000;247(3):397-405.","journal-title":"J Intern Med"},{"issue":"8","key":"key20200602154424_B7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.RES.85.8.753","article-title":"Oxidative stress as a regulator of gene expression in the vasculature","volume":"85","author":"Kunsch","year":"1999","unstructured":"7. Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature. Circ Res.1999;85(8):753-66.","journal-title":"Circ Res"},{"issue":"8","key":"key20200602154424_B8","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-016-0605-2","article-title":"Erratum to: plaque rupture and thrombosis: the value of the atherosclerotic rabbit model in defining the mechanism","volume":"18","author":"Abela","year":"2016","unstructured":"8. Abela OG, Ahsan CH, Alreefi F, Salehi N, Baig I, Janoudi A, et al. Erratum to: plaque rupture and thrombosis: the value of the atherosclerotic rabbit model in defining the mechanism. Curr Atheroscler Rep. 2016;18(8):52.","journal-title":"Curr Atheroscler Rep"},{"issue":"25","key":"key20200602154424_B9","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.jacc.2008.01.069","article-title":"Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes","volume":"51","author":"Mega","year":"2008","unstructured":"9. Mega JL, Morrow DA, Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes. J Am Coll Cardiol. 2008;51(25):2422-9.","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"key20200602154424_B10","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1161\/ATVBAHA.109.202697","article-title":"Interleukin-18 as a predictor of future events in patients with acute coronary syndromes","volume":"30","author":"Hartford","year":"2010","unstructured":"10. Hartford M, Wiklund O, Hult\u00e9n LM, Persson A, Karlsson T, Herlitz J, et al. Interleukin-18 as a predictor of future events in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol. 2010;30(10):2039-46.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"key20200602154424_B11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000350403","article-title":"Inflammatory markers may predict long-term cardiovascular mortality in patients with acute coronary syndrome","volume":"125","author":"Balta","year":"2013","unstructured":"11. Balta S, Demirkol S, Kucuk U, Unlu M, Ay SA, Arslan Z, et al. Inflammatory markers may predict long-term cardiovascular mortality in patients with acute coronary syndrome. Cardiology. 2013;125(2):88-9.","journal-title":"Cardiology"},{"issue":"5","key":"key20200602154424_B12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1089\/met.2015.0130","article-title":"Combined elevated levels of the proinflammatory cytokines IL-18 and IL-12 are associated with clinical events in patients with coronary artery disease: an observational study","volume":"14","author":"Opstad","year":"2016","unstructured":"12. Opstad TB, Arnesen H, Pettersen A\u00c5, Seljeflot I. Combined elevated levels of the proinflammatory cytokines IL-18 and IL-12 are associated with clinical events in patients with coronary artery disease: an observational study. Metab Syndr Relat Disord. 2016;14(5):242-8.","journal-title":"Metab Syndr Relat Disord"},{"issue":"5","key":"key20200602154424_B13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/heart.88.5.467","article-title":"Increased plasma concentrations of interleukin-18 in acute coronary syndromes","volume":"88","author":"Mallat","year":"2002","unstructured":"13. Mallat Z, Henry P, Fressonnet R, Alouani S, Scoazec A, Beaufils P, et al. Increased plasma concentrations of interleukin-18 in acute coronary syndromes. Heart. 2002;88(5):467-9.","journal-title":"Heart"},{"issue":"1","key":"key20200602154424_B14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina","volume":"106","author":"Blankenberg","year":"2002","unstructured":"14. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106(1):24-30.","journal-title":"Circulation"},{"key":"key20200602154424_B15","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2840-10-110","article-title":"Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A\/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study","volume":"10","author":"Opstad","year":"2011","unstructured":"15. Opstad TB, Pettersen AA, Arnesen H, Seljeflot I. Circulating levels of IL-18 are significantly influenced by the IL-18 +183 A\/G polymorphism in coronary artery disease patients with diabetes type 2 and the metabolic syndrome: an observational study. Cardiovasc Diabetol. 2011 Dec 5;10:110.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"key20200602154424_B16","first-page":"177","article-title":"High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus","volume":"16","author":"Suchanek","year":"2005","unstructured":"16. Suchanek H, My\u015bliwska J, Siebert J, Wieckiewicz J, Hak \u0141, Szyndler K, et al. High serum interleukin-18 concentrations in patients with coronary artery disease and type 2 diabetes mellitus. Eur Cytokine Netw. 2005;16(3):177-85.","journal-title":"Eur Cytokine Netw"},{"issue":"8","key":"key20200602154424_B17","first-page":"685","volume":"18","author":"Jin","year":"2017","unstructured":"17. Jin DY, Liu CL, Tang JN, Zhu ZZ, Xuan XX, Zhu XD, et al. Interleukin-18, matrix metalloproteinase-22 and -29 are independent risk factors of human coronary heart disease. 2017;18(8):685-95.","journal-title":"Interleukin-18, matrix metalloproteinase-22 and -29 are independent risk factors of human coronary heart disease"},{"issue":"3","key":"key20200602154424_B18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s12012-014-9296-5","article-title":"The correlation between plasma tissue factor and interleukin 18 and their significance in patients with acute coronary syndrome","volume":"15","author":"Li","year":"2015","unstructured":"18. Li Q, Kuang Y, Qiu J, Zhang X, Ruan Y, Li Z. The correlation between plasma tissue factor and interleukin 18 and their significance in patients with acute coronary syndrome. Cardiovasc Toxicol. 2015;15(3):276-82.","journal-title":"Cardiovasc Toxicol"},{"issue":"25","key":"key20200602154424_B19","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.jacc.2008.02.073","article-title":"Markers of activated coagulation in acute coronary syndromes","volume":"51","author":"Goetze","year":"2008","unstructured":"19. Goetze JP. Markers of activated coagulation in acute coronary syndromes. J Am Coll Cardiol. 2008;51(25):2430-1.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"key20200602154424_B20","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.jacc.2008.01.069","article-title":"Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes","volume":"51","author":"Mega","year":"2008","unstructured":"20. Mega JL, Morrow DA, Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS. Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes. J Am Coll Cardiol. 2008;51(25):2422-9.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"key20200602154424_B21","first-page":"338","article-title":"Thrombus precursor protein and the measurement of thrombosis in patients with acute chest pain syndrome","volume":"27","author":"Laurino","year":"1997","unstructured":"21. Laurino JP, Pelletier TE, Eadry R, Kounavis A. Thrombus precursor protein and the measurement of thrombosis in patients with acute chest pain syndrome. Ann Clin Lab Sci. 1997;27(5):338-45.","journal-title":"Ann Clin Lab Sci"},{"issue":"16","key":"key20200602154424_B22","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1093\/eurheartj\/ehn331","article-title":"Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study","volume":"29","author":"Empana","year":"2008","unstructured":"22. Empana JP, Canoui-Poitrine F, Luc G, Juhan-Vague I, Morange P, Arveiler D, et al. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME Study. Eur Heart J. 2008;29(16):1966-74.","journal-title":"Eur Heart J"},{"issue":"7","key":"key20200602154424_B23","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/01.CIR.0000050621.67499.7D","article-title":"Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity","volume":"107","author":"Sambola","year":"2003","unstructured":"23. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation. 2003;107(7):973-7.","journal-title":"Circulation"},{"issue":"12","key":"key20200602154424_B24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.jhh.1000556","article-title":"The role of rheological and haemostatic factors in hypertension","volume":"11","author":"Lee","year":"1997","unstructured":"24. Lee AJ. The role of rheological and haemostatic factors in hypertension. J Hum Hypertens. 1997;11(12):767-76.","journal-title":"J Hum Hypertens"}],"container-title":["Arquivos Brasileiros de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.scielo.br\/pdf\/abc\/v114n4\/0066-782X-abc-114-04-0692.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:44:23Z","timestamp":1614962663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0066-782X2020000400692&lng=pt&nrm=iso"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5,12]]}},"alternative-id":["10.36660\/abc.20190176"],"URL":"https:\/\/doi.org\/10.36660\/abc.20190176","relation":{},"ISSN":["0066-782X","1678-4170"],"issn-type":[{"type":"print","value":"0066-782X"},{"type":"electronic","value":"1678-4170"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}